Stock listing

HKEX:6667 Mega Genomics Limited (美因基因) 股價

Follow Mega Genomics Limited into a list and get an email when it puts out news.

Share price · HKEX:6667

$6.90 HKD +0.23 (+3.5%)

Close on Nov 20, 2026

Past year -4.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$6.89 – $6.90 HKDNov 20, 2026
Volume
3,000 sharesNov 20, 2026
Market cap
$1.52B HKDAt the close on Nov 20, 2026 · price × 220.3M shares outstanding
52-week range
$5.00 – $7.53 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$486,183 HKDMedian day 73,200 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Mega Genomics Limited logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:6667 · HKD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$6.895+0.23+3.5%$6.895$6.895$6.893,000
$6.665-0.01-0.1%$6.665$6.665$6.6553,200
$6.675-0.005-0.1%$6.675$6.675$6.6653,800
$6.680.000.0%$6.68$6.68$6.680
$6.68+0.01+0.1%$6.68$6.68$6.6654,000
$6.67+0.21+3.3%$6.64$6.685$6.642,000
$6.46-0.33-4.9%$6.685$6.685$6.463,200
$6.79-0.105-1.5%$6.795$6.795$6.774,200
$6.895+0.005+0.1%$6.87$6.895$6.87130,800
$6.89-0.005-0.1%$6.585$6.895$6.584,000
$6.895-0.05-0.7%$6.585$6.895$6.584,000
$6.945-0.055-0.8%$6.99$6.995$6.60112,600
$7.00-0.035-0.5%$7.05$7.05$6.7310,800
$7.035-0.04-0.6%$7.075$7.075$6.8068,000
$7.075+0.12+1.7%$7.12$7.12$6.754,400
$6.955-0.04-0.6%$7.14$7.215$6.8957,200
$6.995-0.095-1.3%$7.085$7.085$6.804,800
$7.09-0.05-0.7%$7.085$7.09$6.9855,600
$7.14+0.02+0.3%$7.205$7.205$7.07583,400
$7.12-0.055-0.8%$7.25$7.25$7.12118,400
$7.175+0.055+0.8%$7.12$7.20$7.12104,800
$7.12+0.02+0.3%$7.10$7.215$7.10148,800
$7.10-0.09-1.3%$7.185$7.185$7.03122,800
$7.19-0.03-0.4%$7.22$7.245$7.16119,200
$7.22+0.145+2.0%$7.075$7.225$6.91123,600
$7.075+0.02+0.3%$7.055$7.175$7.055128,000
$7.055-0.095-1.3%$6.995$7.07$6.92120,000
$7.150.000.0%$7.23$7.235$7.125121,200
$7.15-0.025-0.3%$7.25$7.25$7.12190,600
$7.175-0.095-1.3%$7.30$7.30$7.155189,600
$7.27+0.05+0.7%$7.22$7.295$6.905202,400
$7.22+0.19+2.7%$7.03$7.295$7.03200,400
$7.03-0.02-0.3%$7.045$7.045$7.005120,200
$7.05+0.035+0.5%$7.08$7.085$6.79593,200
$7.015-0.105-1.5%$7.20$7.29$6.99113,000
$7.12+0.035+0.5%$7.085$7.15$6.795114,400
$7.085+0.125+1.8%$6.96$7.25$6.845114,200
$6.96-0.135-1.9%$6.995$7.00$6.65113,400
$7.095+0.05+0.7%$7.035$7.095$6.70123,000
$7.045+0.11+1.6%$7.12$7.20$6.90121,200
$6.935-0.02-0.3%$6.935$6.945$6.60139,000
$6.955-0.06-0.9%$7.01$7.01$6.94120,000
$7.015+0.51+7.8%$6.51$7.025$6.51126,000
$6.505-0.545-7.7%$6.995$6.995$6.50130,400
$7.05-0.075-1.1%$7.125$7.125$7.04578,400
$7.125-0.02-0.3%$7.175$7.175$7.115121,000
$7.145-0.045-0.6%$7.185$7.185$7.135118,400
$7.19+0.02+0.3%$7.20$7.20$7.1661,400
$7.17-0.005-0.1%$7.17$7.195$7.1466,600
$7.175+0.12+1.7%$7.07$7.29$7.05138,800
$7.055-0.01-0.1%$7.08$7.08$7.0551,800
$7.065-0.01-0.1%$7.085$7.095$7.0652,400
$7.075-0.02-0.3%$7.095$7.13$7.0652,000
$7.095+0.02+0.3%$7.075$7.12$7.072,200
$7.075-0.015-0.2%$7.09$7.09$7.0553,200
$7.09-0.005-0.1%$7.095$7.095$7.073,000
$7.095-0.005-0.1%$7.10$7.16$7.0951,800
$7.10+0.005+0.1%$7.08$7.10$7.062,200
$7.0950.000.0%$7.085$7.095$7.0352,400
$7.0950.000.0%$7.095$7.095$7.061,800
$7.0950.000.0%$7.095$7.095$7.042,800
$7.0950.000.0%$7.095$7.095$7.0453,600
$7.095+0.005+0.1%$7.09$7.095$7.052,600
$7.09+0.03+0.4%$7.085$7.095$7.072,000
Ticker
HKEX:6667
Asset type
Stock
Exchange
HKEX
Currency
HKD

What changed lately

Latest news

All Mega Genomics Limited news

Mega Genomics Limited on 6ix

News releases
38 in the last 12 months · 38 in all · newest Nov 19, 2026 · oldest 2026

Valuation

Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$1.05B HKD
P/E
47.8×
EV/sales
3.6×
EV/EBITDA
16.4×
Price/book
2.1×
Gross margin
47.5%
Operating margin
15.8%
Net margin
10.9%
Debt to equity
0.1×
Beta
No index for this market yet

Events

QuarterResultsShare move
Q2 2024Sep 26, 2024−1.8%

Open Events

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue247.2M164.2M151.3M145.7M237.2M203.2M123.7M195.2M
Cost of revenue129.8M44.9M63.0M64.0M70.5M57.0M45.2M115.7M
Gross profit117.4M119.3M88.3M81.7M166.7M146.2M78.5M79.5M
Research and development17.3M19.2M22.4M19.4M11.4M4.45M4.39M5.95M
Selling, general and administrative28.0M22.9M44.5M42.9M2.64M1.10M1.39M
Operating income39.1M41.4M18.5M-41.4M103.2M107.2M47.4M29.7M
Depreciation and amortization15.5M14.7M15.1M15.3M13.9M14.0M14.1M13.0M
EBITDA54.6M56.1M33.6M-26.1M117.0M121.2M61.5M42.7M
Interest expense1.33M1.72M1.12M719.0K6.91M16.6M19.6M18.9M
Income before tax32.8M53.6M36.2M-21.4M95.9M94.9M38.3M11.9M
Income tax5.81M8.59M6.14M-3.80M16.9M15.8M8.60M-10.1M
Net income27.0M45.0M30.0M-17.6M79.0M79.1M29.7M22.0M
Earnings per share, basic0.140.220.14-0.090.390.330.120.09

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents415.6M490.3M518.3M399.8M239.1M208.4M52.6M19.9M
Short-term investments20.1M8.70M223.5M5.80M12.8M
Receivables226.0M90.1M123.9M184.8M203.6M130.2M108.1M104.3M
Inventory39.5M4.61M4.41M3.51M3.28M2.97M2.44M2.98M
Current assets727.5M625.6M667.8M619.1M685.4M358.1M184.4M150.3M
Property, plant and equipment69.8M79.3M94.0M49.8M53.0M62.6M75.5M
Total assets832.4M738.5M796.5M705.7M772.2M453.6M263.7M259.1M
Accounts payable137.8M25.4M39.5M34.8M29.2M26.9M12.0M23.0M
Current liabilities200.0M90.6M114.3M81.2M69.8M262.4M53.1M77.8M
Long-term debt16.6M18.7M20.7M0002.65M
Total debt29.4M34.4M48.6M11.0M11.6M169.8M36.9M253.3M
Total liabilities221.5M123.8M151.7M87.7M77.7M277.2M266.4M313.3M
Shareholders' equity610.9M614.7M644.8M618.0M694.5M176.4M-2.70M-58.6M
Shares outstanding197.4M207.4M211.8M206.3M200.9M239.2M239.2M239.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-16.5M57.2M163.7M-6.91M30.6M102.8M37.3M-13.3M
Capital spending-158.0K-775.0K-36.1M-5.19M-4.42M-1.04M-761.0K-14.0M
Free cash flow-16.7M56.4M127.6M-12.1M26.2M101.8M36.5M-27.3M
Cash from investing-16.9M6.63M-33.8M-2.56M-1.71M-31.1M17.7M-23.0M
Cash from financing-41.3M-91.8M-12.9M158.5M2.62M84.1M-20.3M17.7M
Share buybacks-30.8M-77.6M-10.5M184.2M228.8M00
Change in cash-74.7M-28.0M118.5M160.7M30.6M155.8M34.7M19.2M

Open Financials

Filings

FilingDateTypeFiled with
Next Day Disclosure ReturnsNov 19, 2026Next day disclosure returnHKEX
Documents on DisplayNov 11, 2026Notification letterHKEX
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON 27 NOVEMBER 2026Nov 11, 2026Proxy formHKEX
NOTICE OF EXTRAORDINARY GENERAL MEETINGNov 11, 2026Meeting noticeHKEX
CONTINUING CONNECTED TRANSACTIONS - PROPOSED REVISION OF THE 2026 ANNUAL CAP UNDER THE 2024 MEINIAN FRAMEWORK AGREEMENT AND NOTICE OF EXTRAORDINARY GENERAL MEETINGNov 11, 2026Meeting noticeHKEX
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026Nov 11, 2026ResultsHKEX
DELAY IN DESPATCH OF CIRCULAR - CONTINUING CONNECTED TRANSACTIONS - PROPOSED REVISION OF THE 2026 ANNUAL CAP UNDER THE 2024 MEINIAN FRAMEWORK AGREEMENTNov 9, 2026Other filingsHKEX
Next Day Disclosure ReturnsNov 9, 2026Next day disclosure returnHKEX
CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF THE MEINIAN COOPERATION FRAMEWORK AGREEMENT AND THE DR. YU COOPERATION FRAMEWORK AGREEMENTNov 6, 2026Material contractHKEX
Next Day Disclosure ReturnsNov 5, 2026Next day disclosure returnHKEX
All 38 filings
FilingDateTypeFiled with
Next Day Disclosure ReturnsNov 4, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsNov 3, 2026Next day disclosure returnHKEX
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2026Nov 2, 2026Monthly returnHKEX
Next Day Disclosure ReturnsNov 2, 2026Next day disclosure returnHKEX
CONTINUING CONNECTED TRANSACTIONS - PROPOSED REVISION OF THE 2026 ANNUAL CAP UNDER THE 2024 MEINIAN FRAMEWORK AGREEMENTOct 29, 2026Material contractHKEX
Next Day Disclosure ReturnsOct 27, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 26, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 23, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 22, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 21, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 20, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 16, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 15, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 14, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 13, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 12, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 9, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 8, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 7, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 6, 2026Next day disclosure returnHKEX
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2026Oct 5, 2026Monthly returnHKEX
Next Day Disclosure ReturnsOct 5, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsOct 2, 2026Next day disclosure returnHKEX
2026 INTERIM REPORTSep 30, 2026Interim reportHKEX
Next Day Disclosure ReturnsSep 30, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsSep 29, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsSep 28, 2026Next day disclosure returnHKEX
Next Day Disclosure ReturnsJun 23, 2026Next day disclosure returnHKEX

Open Filings

Cap table

Built by 6ix from Mega Genomics Limited’s releases

Common shares
220,293,000
Fully diluted
220,293,000

Fully diluted

LineShares
Common shares220,293,000

Share count over time

CountShares
Nov 22, 2026220,293,000

Open Cap table

Shareholders

Funds

HolderSharesValueChangeAs of
Emerging Markets Social Core Equity Portfolio14,800US$13,521No changeJul 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Mega Genomics Limited.